#eli-lilly

[ follow ]
#pharmaceuticals
Healthcare
fromBusiness Insider
3 months ago

New weight-loss drugs like Mounjaro are hot right now. Eli Lilly's CEO explains why they're so expensive.

Weight-loss drugs are expensive due to the high development costs and the limited time to recoup investment before patents expire.
Wearables
fromNew York Post
1 month ago

Eli Lilly stock surges 15% after clinical trial of weight loss pill shows it works like Ozempic

Eli Lilly's orforglipron shows significant weight loss for Type 2 diabetes patients, potentially rivaling injectable medications.
Lilly's shares surged 15% following promising clinical trial results for orforglipron.
fromFuturism
1 month ago
NYC startup

Eli Lilly's New Weight Loss Drug May Have the Worst Name in Pharmaceutical History

Healthcare
fromBusiness Insider
3 months ago

New weight-loss drugs like Mounjaro are hot right now. Eli Lilly's CEO explains why they're so expensive.

Weight-loss drugs are expensive due to the high development costs and the limited time to recoup investment before patents expire.
Wearables
fromNew York Post
1 month ago

Eli Lilly stock surges 15% after clinical trial of weight loss pill shows it works like Ozempic

Eli Lilly's orforglipron shows significant weight loss for Type 2 diabetes patients, potentially rivaling injectable medications.
Lilly's shares surged 15% following promising clinical trial results for orforglipron.
fromFuturism
1 month ago
NYC startup

Eli Lilly's New Weight Loss Drug May Have the Worst Name in Pharmaceutical History

more#pharmaceuticals
from24/7 Wall St.
5 days ago

Visa, Eli Lilly or Netflix- Which Stock Will Be A Trillion Dollar Company Next?

Visa Inc. is set to benefit from the global transition to digital transactions, boasting a market cap of $716 billion and potential for rapid growth.
Startup companies
#novo-nordisk
fromFast Company
5 months ago
Medicine

Novo Nordisk stock price takes a tumble after the Wegovy maker's next-generation weight-loss drug underwhelms

fromFast Company
5 months ago
Medicine

Novo Nordisk stock price takes a tumble after the Wegovy maker's next-generation weight-loss drug underwhelms

more#novo-nordisk
#stock-market
London startup
from24/7 Wall St.
1 month ago

Eli Lilly Will Be the Next $1 Trillion Stock

Eli Lilly aims to become the first healthcare company with a $1 trillion market cap, spurred by its GLP-1 therapy leadership.
Orforglipron's success in trials positions Lilly for significant market growth in obesity and diabetes management.
from24/7 Wall St.
1 month ago
Cryptocurrency

Here's Why Eli Lilly (NYSE: LLY). Fidelity National (NYSE: FIS) and Diamondback Energy (Nasdaq: FANG) Are Soaring Today

London startup
from24/7 Wall St.
1 month ago

Eli Lilly Will Be the Next $1 Trillion Stock

Eli Lilly aims to become the first healthcare company with a $1 trillion market cap, spurred by its GLP-1 therapy leadership.
Orforglipron's success in trials positions Lilly for significant market growth in obesity and diabetes management.
from24/7 Wall St.
1 month ago
Cryptocurrency

Here's Why Eli Lilly (NYSE: LLY). Fidelity National (NYSE: FIS) and Diamondback Energy (Nasdaq: FANG) Are Soaring Today

more#stock-market
#zepbound
more#zepbound
#orforglipron
Wearables
fromwww.nytimes.com
1 month ago

What to Know About Eli Lilly's Daily Pill for Weight Loss

Eli Lilly's orforglipron offers a potential oral treatment for obesity and diabetes, expanding access beyond current injected options.
Wearables
fromBusiness Insider
1 month ago

Weight loss in a pill? Eli Lilly just took a big step closer to making it happen

Orforglipron, a new oral GLP-1 drug from Eli Lilly, may transform obesity treatment by offering a non-injection alternative.
Wearables
fromNew York Post
1 month ago

Everything to know about the new weight loss pill that works as well as Ozempic - and when you can get it

Eli Lilly's orforglipron offers a stab-free treatment for diabetes and obesity, with potential FDA approval enhancing its market presence.
Wearables
fromwww.nytimes.com
1 month ago

What to Know About Eli Lilly's Daily Pill for Weight Loss

Eli Lilly's orforglipron offers a potential oral treatment for obesity and diabetes, expanding access beyond current injected options.
Wearables
fromBusiness Insider
1 month ago

Weight loss in a pill? Eli Lilly just took a big step closer to making it happen

Orforglipron, a new oral GLP-1 drug from Eli Lilly, may transform obesity treatment by offering a non-injection alternative.
Wearables
fromNew York Post
1 month ago

Everything to know about the new weight loss pill that works as well as Ozempic - and when you can get it

Eli Lilly's orforglipron offers a stab-free treatment for diabetes and obesity, with potential FDA approval enhancing its market presence.
more#orforglipron
#pharmaceutical-industry
US politics
fromwww.aljazeera.com
3 months ago

Eli Lilly plans $27bn in new plants as Trump threatens pharma tariffs

Eli Lilly plans to invest $27 billion in new US plants, creating over 3,000 skilled jobs and responding to potential drug import tariffs.
US politics
fromwww.aljazeera.com
3 months ago

Eli Lilly plans $27bn in new plants as Trump threatens pharma tariffs

Eli Lilly plans to invest $27 billion in new US plants, creating over 3,000 skilled jobs and responding to potential drug import tariffs.
more#pharmaceutical-industry
Exercise
fromwww.nytimes.com
2 months ago

Eli Lilly Drug Reduces Mysterious Lp(a) Particle Involved in Heart Attack Risk

Eli Lilly's experimental drug lepodisiran significantly reduces harmful Lp(a) levels in the blood, potentially aiding cardiovascular health.
fromAdweek
4 months ago

R/GA Wins Eli Lilly Social Business

Eli Lilly has appointed R/GA as its social agency of record to manage social media for its GLP-1 drug, Zepbound, and other brands.
Medicine
[ Load more ]